Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2024)
Sutro Biopharma (STRO) reported Return on Invested Capital of 0.2% for Q3 2024, down 16.0% on a YoY basis from 0.24% in Q4 2023, and down 160.93% sequentially from 0.08% in Q2 2024.
Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2024) Analysis & Trends
Sutro Biopharma (STRO) has 3 years of Return on Invested Capital data on file, last reported at 0.2% in Q3 2024.
- For the quarter ending Q3 2024, Return on Invested Capital fell 16.0% year-over-year to 0.2%; the trailing twelve-month figure through Sep 2024 stood at 0.2% (down 16.0% YoY), and the FY2023 full-year result was 0.13%, down 1.0% from the prior year.
- Return on Invested Capital eased to 0.2% in Q3 2024, from 0.08% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q1 2023 to a low of 0.2% in Q3 2024.
- A 3-year average of 0.06% and a median of 0.03% in 2023 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital changed 0 bps in 2023 and fell 16 bps in 2024, its largest moves.
- Tracing STRO's Return on Invested Capital over 3 years: stood at 0.03% in 2022, then fell by 2 bps to 0.03% in 2023, then tumbled by 616 bps to 0.2% in 2024.
- Business Quant data shows STRO's Return on Invested Capital at 0.2% in Q3 2024, 0.08% in Q2 2024, and 0.03% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -0.20% |
| Jun 30, 2024 | -0.08% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |